Gregory M. C. Orleski
Direttore/Membro del Consiglio presso 10379085 Canada, Inc.
Posizioni attive di Gregory M. C. Orleski
Società | Posizione | Inizio | Fine |
---|---|---|---|
10379085 Canada, Inc.
10379085 Canada, Inc. Financial ConglomeratesFinance 10379085 Canada, Inc. is an investment holding Canadian company founded in 2017. The private company is based in Montréal, Canada. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Gregory M. C. Orleski
Precedenti posizioni note di Gregory M. C. Orleski
Società | Posizione | Inizio | Fine |
---|---|---|---|
CRESCITA THERAPEUTICS INC. | Direttore/Membro del Consiglio | 01/09/2016 | 03/11/2016 |
Amministratore Delegato | 01/09/2016 | 03/11/2016 | |
ABBOTT INDIA LIMITED | Direttore/Membro del Consiglio | 21/09/2007 | 21/09/2007 |
Uman Pharma, Inc.
Uman Pharma, Inc. Pharmaceuticals: GenericHealth Technology Uman Pharma, Inc. develops, manufactures, and markets generic injectable pharmaceutical products. The company was founded in December 20, 2007 and is headquartered in Montreal, Canada. | Direttore/Membro del Consiglio | - | - |
INTEGA Skin Sciences, Inc.
INTEGA Skin Sciences, Inc. Pharmaceuticals: MajorHealth Technology INTEGA Skin Sciences, Inc. is a dermatology company, which offers treatment and care products for skin diseases and their symptoms. The company was founded by Gregory M.C. Orleski in 2015 and is headquartered in Montreal, Canada.^ | Amministratore Delegato | 01/01/2015 | - |
Fondatore | 01/01/2015 | - | |
Presidente | 01/01/2015 | - | |
ABBOTT LABORATORIES | Corporate Officer/Principal | - | - |
Chlorion Pharma, Inc.
Chlorion Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Chlorion Pharma, Inc. Develops small molecule leads for the treatment of naturopathic pain and epilepsy. It develops therapeutics for the treatment of neuropathic pain and epilepsy. The company was founded by Jeffrey A. M. Coull, Yves De Koninck and Martin Gagnon in 2004 and is headquartered in Laval, Canada. | Presidente | 15/10/2009 | - |
Labopharm, Inc.
Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Corporate Officer/Principal | - | - |
Formazione di Gregory M. C. Orleski
McGill University | Graduate Degree |
University of Alberta | Undergraduate Degree |
Statistiche
Distribuzione geografica
Canada | 9 |
Stati Uniti | 2 |
India | 2 |
Posizioni
Director/Board Member | 4 |
Corporate Officer/Principal | 2 |
Chief Executive Officer | 2 |
Settori
Health Technology | 7 |
Consumer Services | 3 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
ABBOTT LABORATORIES | Health Technology |
ABBOTT INDIA LIMITED | Health Technology |
CRESCITA THERAPEUTICS INC. | Health Technology |
Aziende private | 5 |
---|---|
Labopharm, Inc.
Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Health Technology |
Uman Pharma, Inc.
Uman Pharma, Inc. Pharmaceuticals: GenericHealth Technology Uman Pharma, Inc. develops, manufactures, and markets generic injectable pharmaceutical products. The company was founded in December 20, 2007 and is headquartered in Montreal, Canada. | Health Technology |
INTEGA Skin Sciences, Inc.
INTEGA Skin Sciences, Inc. Pharmaceuticals: MajorHealth Technology INTEGA Skin Sciences, Inc. is a dermatology company, which offers treatment and care products for skin diseases and their symptoms. The company was founded by Gregory M.C. Orleski in 2015 and is headquartered in Montreal, Canada.^ | Health Technology |
10379085 Canada, Inc.
10379085 Canada, Inc. Financial ConglomeratesFinance 10379085 Canada, Inc. is an investment holding Canadian company founded in 2017. The private company is based in Montréal, Canada. | Finance |
Chlorion Pharma, Inc.
Chlorion Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Chlorion Pharma, Inc. Develops small molecule leads for the treatment of naturopathic pain and epilepsy. It develops therapeutics for the treatment of neuropathic pain and epilepsy. The company was founded by Jeffrey A. M. Coull, Yves De Koninck and Martin Gagnon in 2004 and is headquartered in Laval, Canada. | Commercial Services |